NCT02795117View on ClinicalTrials.gov

Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Rosacea
Interventions
DRUG

Ivermectin

DRUG

Ivermectin (reference)

DRUG

Placebo

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY